CHAPEL HILL, N.C.--(BUSINESS WIRE)--Nov. 28, 2007--POZEN Inc.
(NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the
company's chairman, president and chief executive officer, will
participate in the "Deliver Us From Pain" panel discussion at the RBC
Capital Markets 2007 Healthcare Conference on Wednesday, December 12,
2007 at 11:00 a.m. (ET) at the Westin Times Square Hotel in New York
City. The event will be webcast and archived on POZEN's home page at
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. POZEN's
efforts are focused primarily on the development of pharmaceutical
products for the treatment of acute and chronic pain and other
pain-related conditions. POZEN has development and commercialization
alliances with GlaxoSmithKline for the proposed product candidate
Trexima(TM) for the acute treatment of migraine, which is currently
under review by the United States Food and Drug Administration, and
with AstraZeneca for the proposed product candidate PN 400 for
conditions such as osteoarthritis and rheumatoid arthritis in patients
who are at risk for developing NSAID-associated gastric ulcers. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
Fran Barsky, 919-913-1044
Director, Investor Relations
SOURCE: POZEN Inc.